
BH renewal relieves overhang but likely 20–25% of prior size; non-license revs fell again, weak trial conversion.
In our prior note, we highlighted several key items we expected C3.ai to clarify this quarter:
This report is available to subscribers. Sign in or subscribe to read the full analysis.